Literature DB >> 20189378

Peritoneal pseudomyxoma arising from the urachus.

Alejandra Martínez1, Gwénael Ferron, Eliane Mery, Laurance Gladieff, Jean Pierre Delord, Denis Querleu.   

Abstract

Pseudomyxoma peritonei (PMP) arising from urachal tumors is extremely rare. To our knowledge, natural history, tumor biological behaviour, morbidity, treatment, and prognosis of PMP arising from the urachus are determined by the associated PMP. Management of urachal tumors with associated PMP should be based on aggressive locorregional therapy with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy, similar to PMP arising from other origins.
Copyright © 2010. Published by Elsevier Ltd.

Entities:  

Mesh：

Year:  2010        PMID： 20189378     DOI： 10.1016/j.suronc.2009.12.004

Source DB:  PubMed          Journal:  Surg Oncol        ISSN： 0960-7404            Impact factor:   3.279


  6 in total

1.  Pseudomyxoma peritonei originating from urachus-case report and review of the literature.

Authors:  A K Agrawal; P Bobiński; Z Grzebieniak; J Rudnicki; G Marek; P Kobielak; M Kazanowski; S Agrawal; A Hałoń
Journal:  Curr Oncol       Date:  2014-02       Impact factor: 3.677

Review 2.  New insights in the pathology of peritoneal surface malignancy.

Authors:  Norman John Carr
Journal:  J Gastrointest Oncol       Date:  2021-04

3.  Pseudomyxoma Peritonei Originating from Transverse Colon Mucinous Adenocarcinoma: A Case Report and Literature Review.

Authors:  Yingbo Gong; Xin Wang; Zhi Zhu
Journal:  Gastroenterol Res Pract       Date:  2020-07-03       Impact factor: 2.260

4.  Urachal mucinous adenocarcinoma with pseudomyxoma peritonei: A case report.

Authors:  Lei Liang; Nan Zhou; Hongbin Xu; Damiao Liu; Yiyan Lu; Fang Li; Jun Guo
Journal:  Medicine (Baltimore)       Date:  2017-09       Impact factor: 1.889

Review 5.  Biomarkers in Urachal Cancer and Adenocarcinomas in the Bladder: A Comprehensive Review Supplemented by Own Data.

Authors:  Henning Reis; Ulrich Krafft; Christian Niedworok; Orsolya Módos; Thomas Herold; Mark Behrendt; Hikmat Al-Ahmadie; Boris Hadaschik; Peter Nyirady; Tibor Szarvas
Journal:  Dis Markers       Date:  2018-03-12       Impact factor: 3.434

6.  Urachal Carcinoma with Peritoneal Dissemination Treated with Chemotherapy and Surgical Resection Leading to Prolonged Survival with No Recurrence.

Authors:  Masato Yasui; Ryosuke Jikuya; Tomoyuki Tatenuma; Kentaro Muraoka; Susumu Umemoto; Masaki Kawai; Tsutomu Kouno; Takeshi Kishida
Journal:  Case Rep Urol       Date:  2018-06-13
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.